Share Email Print

Proceedings Paper

Polymer-bound meso-chlorin e6 for PDT (Invited Paper)
Author(s): Nancy L. Krinick; Ying Sun; D. A. Joyner; R. Reed; John D. Spikes; Richard C. Straight; Jindrich Kopecek
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Two types of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer containing meso- chlorin e6 monoethylene diamine disodium salt (Mce6) were synthesized. The Mce6 was bound via pendant enzymatically degradable oligopeptide side chains (G-F-L-G) in one copolymer and was attached through noncleavable side chains (G) in the other. Preliminary experiments have been undertaken to compare their localization/retention behavior and their tumorcidal activity in vivo (A/J mice; C1300 neuroblastoma). Results of localization/retention experiments indicated that the Mce6 bound to the noncleavable copolymer was retained in the tumor and other tissues for a prolonged time period compared with free Mce6 or the Mce6 bound to the cleavable copolymer. Light activation of the Mce6 from the cleavable copolymer rendered a substantially more potent biological response in vivo than did the permanently bound Mce6. It is hypothesized and indirectly supported by photophysical data that both of the polymer-photosensitizer complexes are aggregated (or conformationally altered) under physiological conditions due to their hydrophilic/hydrophobic properties. In buffer at pH 7.4, the quantum yield of singlet oxygen generation by free Mce6 is three-fold higher than by the Mce6 bound to a noncleavable copolymer; adding detergent (CTAB), increased the quantum yield of singlet oxygen generation to a value consistent with that of the free Mce6. In vivo, if a sufficient time lag is allowed after drug administration for tumor cell lysosomal enzymes to cleave the Mce6 from the polymer containing degradable side chains, the Mce6 would be released in free form and behave with properties akin to the free drug. Due to the difference in cellular uptake mechanisms for free and bound drugs (and the targeting potential of the copolymer), a much higher local concentration in the tumor compared with surrounding tissue can be achieved with the polymer bound drug than the free photosensitizer. Side effects characteristics of current PDT treatment such as light ultrasensitivity in skin may be reduced by improving localization selectivity.

Paper Details

Date Published: 1 June 1992
PDF: 13 pages
Proc. SPIE 1645, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy, (1 June 1992); doi: 10.1117/12.60937
Show Author Affiliations
Nancy L. Krinick, Univ. of Utah (United States)
Ying Sun, Univ. of Utah (United States)
D. A. Joyner, Univ. of Utah (United States)
R. Reed, Univ. of Utah (United States)
John D. Spikes, Univ. of Utah (United States)
Richard C. Straight, Univ. of Utah (United States)
Jindrich Kopecek, Univ. of Utah (United States)

Published in SPIE Proceedings Vol. 1645:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy
Thomas J. Dougherty, Editor(s)

© SPIE. Terms of Use
Back to Top